A carregar...

Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy

BACKGROUND AND OBJECTIVES: Cyclophosphamide treatment improves renal survival in patients with idiopathic membranous nephropathy. However, use of cyclophosphamide is associated with cancer. The incidence of malignancies in patients with idiopathic membranous nephropathy was evaluated, and the cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: van den Brand, Jan A.J.G., van Dijk, Peter R., Hofstra, Julia M., Wetzels, Jack F.M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4046727/
https://ncbi.nlm.nih.gov/pubmed/24855280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.08880813
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!